567 studies found for:    Open Studies | "Ovarian Diseases"
Show Display Options
Rank Status Study
21 Not yet recruiting Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Biological: IGF1R antibody MK0646;   Other: Saline solution
22 Recruiting A Phase I Clinical Study With Investigational Compound LTT462 in Adult Patients With Specific Advanced Cancers
Conditions: Ovarian Neoplasms;   Non-Small-Cell Lung Carcinoma;   Melanoma;   Other Solid Tumors
Intervention: Drug: LTT462
23 Recruiting Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian Cancer
Condition: Ovarian Carcinoma
Interventions: Procedure: Computed Tomography;   Radiation: Copper Cu 64-DOTA B-Fab;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Procedure: Positron Emission Tomography
24 Not yet recruiting Impact of a Psychoeducational Intervention on Expectations and Coping in Young Women Exposed to a High HBOC Risk
Condition: Hereditary Breast and Ovarian Cancer Syndrome
Intervention: Behavioral: psychoeducation
25 Not yet recruiting Identification and Characterization of Ovarian Cancer and Endometrial Cancer Specific Biomarkers in Vaginal Fluids
Condition: Cancer of Ovary
Intervention: Procedure: fluid sample
26 Not yet recruiting Administration of Single High Dose Letrozole for Ovulation Induction
Condition: Anovulation
Intervention: Drug: Letrozole
27 Not yet recruiting Ovarian Hyperstimulation Syndrome in Patients Triggered by GnRH Agonist for Excessive Follicular Response
Conditions: Ovarian Hyperstimulation Syndrome;   Hypercoagulability
Intervention: Other: COAGO
28 Recruiting Rejuvenation of Premature Ovarian Failure With Stem Cells
Condition: Premature Ovarian Failure
Intervention: Procedure: ROSE Protocol
29 Recruiting Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOS
Condition: Polycystic Ovary Syndrome
Interventions: Drug: Cyproterone compound + Spironolactone;   Drug: Metformin;   Drug: Pioglitazone
30 Recruiting The Role of HE4 in the Follow-up of Advanced Ovarian, Fallopian Tube and Primary Peritoneal Cancer
Condition: Ovarian Neoplasms
Intervention: Other: Determination of CA 125 and HE4, Computed tomography
31 Not yet recruiting Treatment for Malignant Ovarian Cancer: Laparoscopy vs Laparotomy
Condition: Ovarian Cancer
Interventions: Procedure: Laparoscopy;   Procedure: Laparotomy
32 Not yet recruiting The Letrozole Administration During Luteal Phase
Condition: Ovarian Hyperstimulation Syndrome
Interventions: Drug: Letrozole;   Drug: Polygeline;   Drug: Sodium Chloride;   Drug: dexamethasone
33 Recruiting Hyperthermic Intraperitoneal Chemotherapy With Paclitaxel in Advanced Ovarian Cancer
Condition: Epithelial Ovarian Cancer
Interventions: Procedure: HIPEC;   Procedure: No HIPEC;   Drug: Paclitaxel;   Drug: carboplatin
34 Not yet recruiting A Study of Cediranib and Olaparib at Disease Worsening in Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Cediranib;   Drug: Olaparib
35 Recruiting STELLA 2 Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer
Conditions: Endometrial Neoplasms;   Ovarian Neoplasms
Interventions: Procedure: Extraperitoneal Laparoscopic aortic lymphadenectomy;   Procedure: Transperitoneal Laparoscopic aortic lymphadenectomy
36 Recruiting AMH, Glucose Intolerance and Metabolic Syndrome in PCOS
Condition: Polycystic Ovary Syndrome
Intervention: Other: serum
37 Recruiting Efficacy and Safety Study of Pembrolizumab (MK-3475) in Women With Advanced Recurrent Ovarian Cancer (MK-3475-100/KEYNOTE-100)
Condition: Ovarian Neoplasms
Intervention: Biological: pembrolizumab
38 Recruiting Circadian Variation in Serum-progesterone Levels Following Controlled Ovarian Hyperstimulation.
Condition: Infertility
Intervention:
39 Recruiting Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Procedure: Hyperthermic intraperitoneal chemotherapy (HIPEC);   Drug: Carboplatin
40 Not yet recruiting MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors
Conditions: Non-Small Cell Lung Cancer;   Nonsmall Cell Lung Cancer;   Breast Cancer;   Cancer of Breast;   Cancer of the Breast;   Gastroesophageal Cancer;   Pancreatic Cancer;   Cancer of the Pancreas;   Colorectal Cancer;   Colorectal Carcinoma;   Renal Cancer;   Kidney Cancer;   Cancer of the Kidney;   Cancer of Kidney;   Ovarian Cancer;   Ovary Cancer;   Cancer of the Ovary;   Cancer of Ovary
Intervention: Drug: MEDI4736

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years